Labcorp Long Term Debt 2010-2023 | LH

Labcorp long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
  • Labcorp long term debt for the quarter ending December 31, 2023 was $4.133B, a 19.31% decline year-over-year.
  • Labcorp long term debt for 2023 was $4.133B, a 19.31% decline from 2022.
  • Labcorp long term debt for 2022 was $5.122B, a 6.88% decline from 2021.
  • Labcorp long term debt for 2021 was $5.501B, a 0.04% decline from 2020.
Labcorp Annual Long Term Debt
(Millions of US $)
2023 $4,133
2022 $5,122
2021 $5,501
2020 $5,503
2019 $5,881
2018 $6,042
2017 $6,345
2016 $5,300
2015 $5,940
2014 $2,683
2013 $2,889
2012 $2,175
2011 $2,086
2010 $1,827
2009 $977
Labcorp Quarterly Long Term Debt
(Millions of US $)
2023-12-31 $4,133
2023-09-30 $4,508
2023-06-30 $5,124
2023-03-31 $5,134
2022-12-31 $5,122
2022-09-30 $5,420
2022-06-30 $5,442
2022-03-31 $5,467
2021-12-31 $5,501
2021-09-30 $5,503
2021-06-30 $5,510
2021-03-31 $5,004
2020-12-31 $5,503
2020-09-30 $5,504
2020-06-30 $5,504
2020-03-31 $5,880
2019-12-31 $5,881
2019-09-30 $6,194
2019-06-30 $6,181
2019-03-31 $5,544
2018-12-31 $6,042
2018-09-30 $6,045
2018-06-30 $6,039
2018-03-31 $6,359
2017-12-31 $6,345
2017-09-30 $7,200
2017-06-30 $5,608
2017-03-31 $5,402
2016-12-31 $5,300
2016-09-30 $5,473
2016-06-30 $5,968
2016-03-31 $5,970
2015-12-31 $5,940
2015-09-30 $6,007
2015-06-30 $6,113
2015-03-31 $6,598
2014-12-31 $2,683
2014-09-30 $2,917
2014-06-30 $2,910
2014-03-31 $2,903
2013-12-31 $2,889
2013-09-30 $2,554
2013-06-30 $2,390
2013-03-31 $2,175
2012-12-31 $2,175
2012-09-30 $2,175
2012-06-30 $1,975
2012-03-31 $1,985
2011-12-31 $2,086
2011-09-30 $1,769
2011-06-30 $1,788
2011-03-31 $1,808
2010-12-31 $1,827
2010-09-30 $921
2010-06-30 $939
2010-03-31 $958
2009-12-31 $977
2009-09-30 $1,280
2009-06-30 $1,291
2009-03-31 $1,591
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $17.372B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.513B 20.18
McKesson (MCK) United States $68.775B 18.41
West Pharmaceutical Services (WST) United States $28.373B 47.97
Cardinal Health (CAH) United States $25.885B 15.56
Align Technology (ALGN) United States $24.450B 49.30
Cooper (COO) United States $19.104B 28.91
Henry Schein (HSIC) United States $9.226B 15.96
DENTSPLY SIRONA (XRAY) United States $6.640B 17.50
Merit Medical Systems (MMSI) United States $4.272B 24.44
STAAR Surgical (STAA) United States $2.521B 79.39
CONMED (CNMD) United States $2.342B 22.05
Patterson (PDCO) United States $2.305B 11.04
Atrion (ATRI) United States $0.709B 36.55
Lifevantage (LFVN) United States $0.078B 12.67
Pro-Dex (PDEX) United States $0.065B 24.53
Biolase (BIOL) United States $0.005B 0.00